RFS
BIIB icon

Rockefeller Financial Services’s Biogen BIIB Stock Holding History

Rockefeller Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$91.3M Buy
286,652
+26,823
+10% +$8.6M 1.44% 23
2017
Q3 		$81.4M Sell
259,829
-2,532
-1% -$750K 1.55% 22
2017
Q2 		$71.2M Buy
262,361
+37,169
+17% +$9.83M 1.41% 25
2017
Q1 		$61.6M Sell
225,192
-4,243
-2% -$1.2M 1.23% 30
2016
Q4 		$65.1M Buy
229,435
+54,543
+31% +$16.2M 1.32% 29
2016
Q3 		$54.7M Buy
174,892
+169,769
+3,314% +$50.3M 1.14% 35
2016
Q2 		$1.24M Buy
5,123
+464
+10% +$122K 0.02% 178
2016
Q1 		$1.21M Buy
4,659
+2,899
+165% +$766K 0.02% 180
2015
Q4 		$539K Buy
1,760
+340
+24% +$97.7K 0.01% 243
2015
Q3 		$414K Buy
1,420
+112
+9% +$37K 0.01% 265
2015
Q2 		$528K Buy
+1,308
New +$525K 0.01% 237
2014
Q3 		– Sell
-65
Closed -$20K – 490
2014
Q2 		$20K Buy
+65
New +$19.6K ﹤0.01% 467
2013
Q3 		– Sell
-3,249
Closed -$699K – 505
2013
Q2 		$699K Buy
+3,249
New +$694K 0.02% 236

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rockefeller Financial Services's BIIB Position: Q4 2017 in Review

Rockefeller Financial Services increased its Biogen (BIIB) stake by 10% in Q4 2017, buying an estimated $8.6M and bringing the position to 286,652 shares worth $91.3M. The position accounts for 1.44% of the portfolio, ranked #23.

Rockefeller Financial Services first reported a position in BIIB in Q2 2013 and has held it in 13 quarters since. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Rockefeller Financial Services held 286,652 shares of Biogen worth $91.3M as of Q4 2017.
  • Rockefeller Financial Services bought 26,823 Biogen shares in Q4 2017, an estimated $8.6M.
  • Biogen made up 1.44% of Rockefeller Financial Services's portfolio in Q4 2017, its #23 holding.
  • Rockefeller Financial Services first reported a position in Biogen in Q2 2013 and has held it in 13 quarters since.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.